Pharmacokinetics and retinal toxicity of intravitreal liposome-encapsulated 5-fluorouridine

José García-Arumí, Roser Pascual, José Fonseca, Francesca Reig Isart, Ricardo Casaroli, Carlos Mateo, Borja Corcóstegui

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)


Background: Fluoropyrimidines may be effective in preventing proliferative vitreoretinopathy after repair of complicated retinal detachments. Liposome encapsulation of these antiproliferative drugs may extend the intravitreal half-life and increase their efficacy. Methods: The current study evaluated the pharma-cokinetic behavior of intravitreally injected 5-fluorouridine (5-FUR), free and encapsulated in liposomes, either conventionally or coated with collagen into 25 New Zealand rabbits. Additionally, we investigated the retinal toxicity of intravitreal injections of 100, 250 and 500 �g as well as 1 mg 5-FUR as free drug or encapsulated in liposomes in the rabbit eye. Results: The half-life of free 5-FUR after liposome injection into the vitreous cavity was 18.17+2.43 h, considerably longer than the half-life of free 5-FUR (0.82 h). Electrophysiologic tests did not show any changes in latency and a-wave amplitude and minimal changes in the b-wave amplitude. Histopathologic studies revealed integrity of the inner limiting membrane, and mild vacuolization in the outer retina. Conclusion: Encapsulation of 5-FUR within liposomes markedly increases its intravitreal half-life. Our study suggests that liposome-encapsulated 5-FUR is not toxic to the retina even at doses of 1 mg. © 1997 S. Karger AG, Basel.
Original languageEnglish
Pages (from-to)344-350
Issue number6
Publication statusPublished - 1 Jan 1997


  • 5-Fluorouridine
  • Antimetabolites
  • Fluoropyrimidines
  • Liposomes
  • Proliferative vitreoretinopathy
  • Retinal toxicity


Dive into the research topics of 'Pharmacokinetics and retinal toxicity of intravitreal liposome-encapsulated 5-fluorouridine'. Together they form a unique fingerprint.

Cite this